Csafe TZ 250mg/31.25mg Injection
Marketer
R.B. Remedies Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Csafe TZ 250mg/31.25mg Injection
TZ-Csafe injection (250mg/31.25mg) combines medications to combat diverse bacterial infections. Its action inhibits microbial proliferation, thus curbing infection spread. Administration must be overseen by a medical professional. Consistent adherence to the prescribed schedule is vital; complete the entire course, even with symptom improvement. Premature cessation can compromise its efficacy. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Escalating side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rashes, itching, swelling, respiratory distress). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is usually unaffected, refrain from driving if drowsiness or dizziness occur. Adequate rest, a nutritious diet, and sufficient hydration are crucial for optimal recovery. Your physician might order lab tests and diagnostics to monitor the treatment's impact.
Uses of Csafe TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Csafe TZ 250mg/31.25mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Csafe TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Csafe TZ 250mg/31.25mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Csafe TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam Injection (Csafe TZ 250mg/31.25mg) unites the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam's role is to counteract bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Csafe TZ 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Csafe TZ 250mg/31.25mg is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Csafe TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Csafe TZ 250mg/31.25mg Injection might cause drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Csafe TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Csafe TZ 250mg/31.25mg requires careful administration in individuals with significant hepatic impairment, potentially necessitating dosage modification. Medical advice is recommended. Dosage alteration for Csafe TZ 250mg/31.25mg Injection is not advised for those with mild or moderate liver dysfunction.
What if you forget to take Csafe TZ 250mg/31.25mg Injection :
Omit a dose of Csafe TZ 250mg/31.25mg Injection? Seek medical advice immediately.
Facts to Know About Csafe TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently